Piette John D, Heisler Michele, Harand Anita, Juip Michelina
Ann Arbor HSR&D Center of Excellence, P.O. Box 130170, Ann Arbor, MI 48113-0170, USA.
J Health Care Poor Underserved. 2010 Feb;21(1):349-61. doi: 10.1353/hpu.0.0247.
This study sought to understand differences across racial groups in diabetes patients' medication-related beliefs and adherence problems due to cost concerns.
We surveyed 806 African American and White diabetes patients about their beliefs regarding medications, cost-related adherence problems, socioeconomic status and communication about treatments with their clinicians.
Many patients endorsed statements such as "Most prescription medications are addictive" (35%) and "Insurance plans push generics to save themselves money at the expense of my health" (65%). African Americans expressed more negative attitudes than White patients and were more likely than White patients to report cost-related medication underuse (19% versus 13%; p5.02). Medication-related attitudes did not explain the higher rates of cost-related medication underuse among Black patients.
Many diabetes patients have negative beliefs about their medications. Other unknown factors however, explain higher rates of cost-related adherence problems among African American compared with White patients.
本研究旨在了解糖尿病患者因费用担忧在药物相关信念及依从性问题上的种族差异。
我们对806名非裔美国人和白人糖尿病患者进行了调查,了解他们对药物的信念、与费用相关的依从性问题、社会经济状况以及与临床医生关于治疗的沟通情况。
许多患者认可诸如“大多数处方药会上瘾”(35%)以及“保险计划为省钱而推广通用药物,却牺牲我的健康”(65%)等说法。非裔美国人比白人患者表达出更多负面态度,且比白人患者更有可能报告因费用相关的药物使用不足情况(19%对13%;p<0.02)。与药物相关的态度并不能解释黑人患者中因费用相关的药物使用不足发生率更高的情况。
许多糖尿病患者对其药物持有负面信念。然而,其他未知因素可解释非裔美国人相比白人患者中因费用相关的依从性问题发生率更高的情况。